Company · next-science-tm-e87da2fb
Next Science TM
4 sourcescompanies-2026-11-14-0.1.0
Cite this record
ConductScience Library. Next Science TM. Companies, record next-science-tm-e87da2fb. Release companies-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/companies/next-science-tm-e87da2fb
On this page
Company
The name as ClinicalTrials.gov gives it. A company is a name ClinicalTrials.gov classes as industry, and spellings that differ only in case or spacing are one; no subsidiary is folded into a parent. A trial of two phases counts in both, and recruiting trials count as active.
- Name
- Next Science TM
- Trials
- 16
- As lead sponsor
- 10
- As collaborator
- 6
- Recruiting
- 3
- Active, recruiting or not
- 3
- Completed
- 6
- Stopped early, withdrawn or suspended
- 7
- Posted results
- 2
- Trials by phase
- Phase 1 1, Phase 2 1, Phase 4 1
- Drugs its trials test
- 1
- Comparisons calculated in its trials
- 2
- First trial registered
- 2014-05-15
- Last update
- 2026-09-18
Source ClinicalTrials.gov
Pipeline1
The drugs its trials test, by the trial links the pipelines release's checks show. The phase is the highest phase those trials registered on ClinicalTrials.gov, not a development stage. Highest phase first, then the most trials.
| Drug | Highest phase registered | Trials | As lead sponsor | Recruiting | Targets | Mechanism | In Drugs and targets |
|---|---|---|---|---|---|---|---|
| BENZALKONIUM CHLORIDE | Phase 4 | 1 | 0 | 0 | https://conductscience.org/library/drugs/CHEMBL502109 |
Source Open Targets
Trials16
The trials that name the company as lead sponsor or collaborator, newest registered first. Results posted are as ClinicalTrials.gov gave them on the day of the sponsors capture.
| Trial | Title | Role | Phase | Status | Type | Participants | Start | Results first posted | Drugs | In Trials | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06831422 | Post-incision Antimicrobial Wash vs C. Acnes in Shoulder Arthroplasty | Collaborator | Not applicable | Recruiting | Interventional | 150 | 2025-05-05 | https://conductscience.org/library/trials/NCT06831422 | ClinicalTrials.gov | ||
| NCT06119750 | 4-Day Primary Irritation Patch Test of MIS Solution | Lead sponsor | Not applicable | Completed | Interventional | 33 | 2020-07-06 | https://conductscience.org/library/trials/NCT06119750 | ClinicalTrials.gov | ||
| NCT05519007 | Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone | Collaborator | Not applicable | Recruiting | Interventional | 936 | 2023-09-26 | https://conductscience.org/library/trials/NCT05519007 | ClinicalTrials.gov | ||
| NCT05517278 | Clinical Evaluation of the Next Science SurgX Antimicrobial Wound Gel Impact on Surgical Site Complications | Collaborator | Not applicable | Withdrawn | Interventional | 0 | 2024-01 | https://conductscience.org/library/trials/NCT05517278 | ClinicalTrials.gov | ||
| NCT04906642 | Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures | Lead sponsor | Not applicable | Terminated | Interventional | 17 | 2021-05-04 | https://conductscience.org/library/trials/NCT04906642 | ClinicalTrials.gov | ||
| NCT04265170 | Evaluating Blast-X® in Combination With Negative Pressure Wound Therapy | Collaborator | Not applicable | Completed | Interventional | 20 | 2019-10-24 | https://conductscience.org/library/trials/NCT04265170 | ClinicalTrials.gov | ||
| NCT04053946 | Clinical Assessment of Next Science Wound Gels in Healing Below the Knee Amputation Surgical Wound Compared to SOC | Lead sponsor | Not applicable | Withdrawn | Interventional | 0 | 2019-10-01 | https://conductscience.org/library/trials/NCT04053946 | ClinicalTrials.gov | ||
| NCT04042857 | Safety and Efficacy of Next Science Gel on Toenail Fungus | Lead sponsor | Not applicable | Recruiting | Interventional | 20 | 2019-07-26 | https://conductscience.org/library/trials/NCT04042857 | ClinicalTrials.gov | ||
| NCT03876548 | Initial Assessment of a Topical Cadexomer Iodine Gel Efficacy on Keloid Scar Revision | Lead sponsor | Early phase 1 | Withdrawn | Interventional | 0 | 2019-02-07 | https://conductscience.org/library/trials/NCT03876548 | ClinicalTrials.gov | ||
| NCT03738579 | Evaluating Wound Healing With Next Science Gel & Wash. | Lead sponsor | Not applicable | Terminated | Interventional | 10 | 2018-10-17 | https://conductscience.org/library/trials/NCT03738579 | ClinicalTrials.gov |
1 to 10 of 16
See all 16 trialsConditions21
The conditions its trials name, as the trials write them, with case and spacing folded. The most trials first.
| Condition | Trials |
|---|---|
| Acne Vulgaris | 2 |
| Surgical Wound Infection | 2 |
| Wound Infection | 2 |
| Amputation Stump; Infection | 1 |
| Chronic Wound | 1 |
| Healthy | 1 |
| Irritation/Irritant | 1 |
| Joint Infection | 1 |
| Keloid Scar Following Surgery | 1 |
| Onychomycosis of Toenail | 1 |
1 to 10 of 21Source ClinicalTrials.gov
See all 21 conditionsPartners17
The other organizations its trials name, as lead sponsor or collaborator, with the class ClinicalTrials.gov gives each. The most trials shared first. A partner that is a company opens its own record.
| Organization | Class | Trials shared | In Companies | Source |
|---|---|---|---|---|
| Jacksonville Center For Clinical Research | Other | 3 | ClinicalTrials.gov | |
| Northwell Health | Other | 2 | ClinicalTrials.gov | |
| Doctors Research Network | Unknown | 1 | ClinicalTrials.gov | |
| Fleming Island Center for Clinical Research | Unknown | 1 | ClinicalTrials.gov | |
| Georgetown University | Other | 1 | ClinicalTrials.gov | |
| Henry Ford Health System | Other | 1 | ClinicalTrials.gov | |
| Hughston Clinic | Other | 1 | ClinicalTrials.gov | |
| Mayo Clinic | Other | 1 | ClinicalTrials.gov | |
| NTS Ventures | Unknown | 1 | ClinicalTrials.gov | |
| Piedmont Healthcare | Other | 1 | ClinicalTrials.gov |
1 to 10 of 17
See all 17 partnersData dates
The date of each source this release read.
Sources 4
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL
- ClinicalTrials.govNo license stated
- Open TargetsCC0 1.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBLCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this company from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/companies/v1/next-science-tm-e87da2fb
GET https://conductscience.org/api/companies/v1/next-science-tm-e87da2fb/conditions?page=2